Everything on M&A Trends

Q1 2026 recorded 22 mega-deals exceeding $10 billion in volume, surpassing the 2015 record of 21 deals. This surge indicates robust corporate confidence and aggressive consolidation despite macroeconomic uncertainties.

Impact: High deal volumes suggest continued market consolidation, creating opportunities for M&A advisory firms and signaling strong cash deployment by acquirers.

— from SpaceX IPO Filing, Record M&A, and Crypto Quantum Risks · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Apr 02, 2026

Biotech M&A activity intensified with Biogen acquiring Appellis and Eli Lilly acquiring Centessa, both deals valued near $6 billion. Target stocks surged over 50%, while acquirer shares remained flat due to deal sizes relative to market capitalization.

Impact: Large-cap pharma firms are aggressively securing innovation pipelines, creating volatility in smaller biotech names and testing acquirer valuation discipline.

— from Unilever Divests Food Business, Nvidia Bolsters AI Chip Alliance, Buffett Remains Active · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Apr 01, 2026